Your browser doesn't support javascript.
loading
MRI-ARSACS: An Imaging Index for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) Identification Based on the Multicenter PROSPAX Study.
Scaravilli, Alessandra; Negroni, Davide; Senatore, Claudio; Ugga, Lorenzo; Cosottini, Mirco; Ricca, Ivana; Bender, Benjamin; Traschütz, Andreas; Basak, Ayse Nazli; Vural, Atay; van de Warrenburg, Bart P; Durr, Alexandra; La Piana, Roberta; Timmann, Dagmar; Schüle, Rebecca; Synofzik, Matthis; Santorelli, Filippo Maria; Cocozza, Sirio.
Afiliação
  • Scaravilli A; Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.
  • Negroni D; Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.
  • Senatore C; Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.
  • Ugga L; Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.
  • Cosottini M; Department of Translational Research on New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Ricca I; Department of Molecular Medicine, IRCCS Stella Maris Foundation, Pisa, Italy.
  • Bender B; Department of Diagnostic and Interventional Neuroradiology, University of Tübingen, Germany.
  • Traschütz A; Division Translational Genomics of Neurodegenerative Diseases, Center for Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Basak AN; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
  • Vural A; Translational Medicine Research Center, KUTTAM-NDAL, Koç University, Istanbul, Turkey.
  • van de Warrenburg BP; Department of Neurology, Koç University, Istanbul, Turkey.
  • Durr A; Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • La Piana R; ICM, Inserm, CNRS, AP-HP, Paris Brain Institute, Sorbonne University, Paris, France.
  • Timmann D; Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
  • Schüle R; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Essen University Hospital, Essen, Germany.
  • Santorelli FM; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
  • Cocozza S; Division of Neurodegenerative Diseases, Department of Neurology, Heidelberg University Hospital and Faculty of Medicine, Heidelberg, Germany.
Mov Disord ; 39(8): 1343-1351, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38847051
ABSTRACT

BACKGROUND:

Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) and hereditary spastic paraplegia type 7 (SPG7) represent the most common genotypes of spastic ataxia (SPAX). To date, their magnetic resonance imaging (MRI) features have only been described qualitatively, and a pure neuroradiological differential diagnosis between these two conditions is difficult to achieve.

OBJECTIVES:

To test the performance of MRI measures to discriminate between ARSACS and SPG7 (as an index of common SPAX disease).

METHODS:

In this prospective multicenter study, 3D-T1-weighted images of 59 ARSACS (35.4 ± 10.3 years, M/F = 33/26) and 78 SPG7 (54.8 ± 10.3 years, M/F = 51/27) patients of the PROSPAX Consortium were analyzed, together with 30 controls (45.9 ± 16.9 years, M/F = 15/15). Different linear and surface measures were evaluated. A receiver operating characteristic analysis was performed, calculating area under the curve (AUC) and corresponding diagnostic accuracy parameters.

RESULTS:

The pons area proved to be the only metric increased exclusively in ARSACS patients (P = 0.02). Other different measures were reduced in ARSACS and SPG7 compared with controls (all with P ≤ 0.005). A cut-off value equal to 1.67 of the pons-to-superior vermis area ratio proved to have the highest AUC (0.98, diagnostic accuracy 93%, sensitivity 97%) in discriminating between ARSACS and SPG7.

CONCLUSIONS:

Evaluation of the pons-to-superior vermis area ratio can discriminate ARSACS from other SPAX patients, as exemplified here by SPG7. Hence, we hereby propose this ratio as the Magnetic Resonance Index for the Assessment and Recognition of patients harboring SACS mutations (MRI-ARSACS), a novel diagnostic tool able to identify ARSACS patients and useful for discriminating ARSACS from other SPAX patients undergoing MRI. © 2024 International Parkinson and Movement Disorder Society.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Paraplegia Espástica Hereditária / Ataxias Espinocerebelares / Espasticidade Muscular Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Paraplegia Espástica Hereditária / Ataxias Espinocerebelares / Espasticidade Muscular Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália